---
layout: minimal-medicine
title: Ifosfamide
---

# Ifosfamide
### Generic Name
Ifosfamide

### Usage

Ifosfamide is a type of chemotherapy drug called an alkylating agent.  Its primary use is in combination with other antineoplastic agents (cancer-fighting drugs) for the treatment of germ cell testicular cancer, typically as a third-line therapy (used after two other treatments have failed).  This means it's often used when other options haven't been effective.  

Importantly, Ifosfamide is also used *off-label* in various other cancers, including advanced bladder cancer, recurrent or metastatic cervical cancer, Ewing sarcoma, relapsed or refractory Hodgkin lymphoma, non-Hodgkin lymphomas (such as Burkitt lymphoma and diffuse large B-cell lymphoma), osteosarcoma, advanced (platinum-resistant) ovarian cancer, and soft tissue sarcoma.  "Off-label" means the drug's use in these cancers isn't officially approved by regulatory agencies, but it's sometimes prescribed by oncologists based on clinical experience and research suggesting potential benefits.  The specific regimen (combination of drugs and dosages) varies widely depending on the type and stage of cancer.

### Dosage

Ifosfamide dosage is highly individualized and depends significantly on the specific cancer being treated, the patient's age, weight, overall health, and response to treatment.  It's administered intravenously (IV). Dosage is usually calculated based on body surface area (BSA) in mg/m².  The following are examples of regimens used in different cancers,  but this is *not* an exhaustive list and should not be interpreted as a prescription.  **Always consult with an oncologist for accurate dosage instructions.**

* **Testicular Cancer:** Often 1200 mg/m²/day for 5 days every 3 weeks, in combination with other drugs and mesna (a drug to protect against bladder toxicity).
* **Other Cancers (Off-label Use):**  Dosages vary greatly (e.g., 1500-3000 mg/m²/day for various durations and schedules), always given in combination with other medications within specific regimens like ICE, VIP, VeIP, or others tailored to the specific cancer.


**Pediatric Dosage:**  Dosage in children is also calculated based on BSA and is usually lower than adult doses.  Similar to adult usage, pediatric regimens often combine Ifosfamide with other drugs.  Always refer to pediatric oncology guidelines and a pediatric oncologist for precise dosing.

**Dosage Adjustments:**  Dose adjustments are often necessary based on factors like kidney or liver function, bone marrow suppression, and overall toxicity.  Your doctor will monitor these carefully and adjust the dosage accordingly.

### Side Effects

Common side effects of Ifosfamide can include:

* Nausea and vomiting
* Hair loss (alopecia)
* Anemia (low red blood cell count)
* Leukopenia (low white blood cell count)
* Thrombocytopenia (low platelet count)
* Bone marrow suppression
* Kidney damage (nephrotoxicity)
* Liver dysfunction
* Hemorrhagic cystitis (bleeding in the bladder)
* Encephalopathy (brain dysfunction)
* Metabolic acidosis (increased acidity in the blood)
* Fatigue
* Fever
* Infections (due to weakened immune system)

Less common, but potentially serious, side effects include heart problems (cardiotoxicity),  pulmonary toxicity (lung damage),  and an increased risk of secondary cancers (new cancers developing later in life).

**If you experience any side effects, particularly severe ones, contact your doctor immediately.**

### How it Works

Ifosfamide is an alkylating agent. It works by damaging the DNA of cancer cells, preventing them from multiplying and ultimately leading to their death.  It does this by creating cross-links within the DNA strands, interfering with normal cell processes like DNA replication and protein synthesis.


### Precautions

* **Hypersensitivity:** Ifosfamide is contraindicated (should not be used) in individuals with a known allergy to Ifosfamide or any of its components.
* **Renal and Hepatic Impairment:**  Ifosfamide can be significantly more toxic to those with impaired kidney or liver function. Dosage adjustments are crucial, and the drug may be contraindicated in severe cases.
* **Bone Marrow Suppression:**  Ifosfamide significantly suppresses bone marrow function, increasing the risk of infections and bleeding.  Blood counts must be monitored closely.
* **Hemorrhagic Cystitis:** Ifosfamide can cause severe bleeding in the bladder.  The protective agent mesna is usually administered concurrently to reduce this risk.
* **CNS Toxicity:**  Ifosfamide can cause serious central nervous system effects, including encephalopathy.  Close monitoring for neurological symptoms is essential.
* **Drug Interactions:**  Ifosfamide can interact with other drugs, potentially increasing the risk of side effects or reducing its effectiveness.  Disclose all medications to your doctor.
* **Pregnancy and Breastfeeding:** Ifosfamide is harmful to a developing fetus and should not be used during pregnancy.  It's also excreted in breast milk, and breastfeeding should be avoided during treatment.


### FAQs

* **Q: How is Ifosfamide stored?** A:  Follow your pharmacist's instructions for proper storage.  It typically requires refrigeration.
* **Q: How long does it take to work?** A: Ifosfamide is a chemotherapy drug, and its effects aren't immediate. It usually takes several weeks or months to see noticeable results.
* **Q:  Is Ifosfamide a cure for cancer?** A: Ifosfamide is a chemotherapy drug used to treat cancer, but it is not a guaranteed cure. Treatment success depends on several factors, including the type and stage of cancer, overall health, and response to treatment.
* **Q: What should I do if I miss a dose?** A:  Contact your oncologist or healthcare provider immediately to discuss the missed dose and get instructions on how to proceed. Never try to adjust the dosage on your own.


**Disclaimer:** This information is for educational purposes only and does not constitute medical advice.  Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.  The information provided here may not be comprehensive, and specific treatment regimens should be determined by an oncologist based on the individual patient's needs.
